BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2996149)

  • 1. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of thromboxane receptors in human platelets.
    Jones RL; Wilson NH; Armstrong RA
    Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelin and platelet function.
    Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
    Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
    Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
    Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
    Cox AD; Devine DV
    Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonate-induced fibrinogen binding to thrombin-degranulated rabbit platelets is independent of released ADP.
    Harfenist EJ; Guccione MA; Packham MA; Kinlough-Rathbone RL; Mustard JF
    Blood; 1982 May; 59(5):956-62. PubMed ID: 6280787
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
    Gralnick HR; Williams SB; Coller BS
    Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet structure and function: immunocytochemical localizations of membrane glycoprotein and alpha-granule protein].
    Suzuki H; Yamazaki H; Tanoue K
    Nihon Rinsho; 1992 Feb; 50(2):218-22. PubMed ID: 1319510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
    Altman R; Rouvier J; Weisenberger H
    Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS; Vilaire G; Burch JW
    J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids.
    Lagarde M; Croset M; Guichardant M; Dechavanne M
    Adv Exp Med Biol; 1985; 192():327-35. PubMed ID: 3938923
    [No Abstract]   [Full Text] [Related]  

  • 18. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation.
    Timmons S; Hawiger J
    Trans Assoc Am Physicians; 1986; 99():226-35. PubMed ID: 3496699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.